AMSilk Announces the Addition of Jeff Davis to its Advisory Board
News Apr 10, 2012
AMSilk has announced the appointment of Jeff Davis, a senior business executive, to AMSilk’s advisory board.
Jeff Davis brings with him more than 23 years of executive experience in sales, marketing and general management in global pharmaceuticals, consumer package goods and beauty businesses from Procter & Gamble, a world leader in consumer care products.
Jeff served in several key roles at P&G including: director of global new business development at P&G Pharmaceuticals; he spearheaded the opening of new markets in Eastern Europe in the early nineties and served as global Vice President & General Manager of Wella, Germany, after its acquisition through P&G.
Jeff has worked in 6 different product groups and 5 different countries.
More recently, as the CEO of Orabrush Inc., an innovative oral care product company targeting the young consumer, Jeff has developed marketing strategies for consumer products using social media with unprecedented success.
He, lectures as an adjunct Professor at the David Eccles School of Business at the University of Utah, and advises Ernst & Young’s business consulting practice for their elite worldwide clients.
“Jeff’s contributions to our product strategy are already significant and this couldn’t have come at a better time,” says Axel Leimer, CEO of AMSilk.
Leimer continued, “AMSilk’s ambitious goals of bringing Spidersilk and related novel high performance materials to market will benefit greatly from his experience.”
“I am excited to work with AMSilk. Having followed AMSilk for some time, I have seen the focus shift from technology to product development,” says Jeff.
Jeff continued, “Spidersilk is a true cleantech material for safer products with a new range of properties. It shows what is possible if we learn from nature.”
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE